After months of melodrama and acrimonious exchanges between Jim Cornelius and Carl Icahn, Eli Lilly, not Bristol-Myers Squibb, will acquire ImClone and gain access to the multibillion dollar Erbitux
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Pfizer announced that it will cut R&D jobs and abandon its research efforts in the areas of cardiovascular diseases, cholesterol management, osteoporosis, anemia and liver and muscle diseases. The co
read more » Discuss Add this link to...Bury Add to:
| Bookmarks